Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: A Prospective Comparative Study Involving Multiple Units to Evaluate the Efficacy and Safety of Telitacicept and Belimumab in the Treatment of Systemic Lupus Erythematosus.

View source ↗

Summary

A prospective comparative study will evaluate the efficacy and safety of Telitacicept and Belimumab in systemic lupus erythematosus. The study is not yet recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BENLYSTA (belimumab)
  • Telitacicept

Snippet

Sponsor: Yipeng Liu | Conditions: Systemic Lupus Erythematosus | Status: NOT_YET_RECRUITING